(Q34005807)

30 July 2017

1 reference

title

A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections (English)

1 reference

30 July 2017

1 reference

S Leflore

1

1 reference

30 July 2017

P L Anderson

series ordinal

2

1 reference

30 July 2017

C V Fletcher

series ordinal

3

1 reference

30 July 2017

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

23

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

131-142

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200023020-00004

30 July 2017

exact match

0 references

cites work

Oral acyclovir prophylaxis against herpes simplex virus in non-Hodgkin lymphoma and acute lymphoblastic leukaemia patients receiving remission induction chemotherapy. A randomised double blind, placebo controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00002018-200023020-00004

Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial

21 January 2018

1 reference

12 December 2020

Acyclovir prophylaxis of herpes-simplex-virus infections

1 reference

12 December 2020

Antimicrobial prophylaxis in bone marrow transplantation

1 reference

12 December 2020

Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study

1 reference

12 December 2020

Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial

1 reference

12 December 2020

Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial

1 reference

12 December 2020

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir

1 reference

12 December 2020

Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Prophylactic oral acyclovir after renal transplantation

1 reference

12 December 2020

Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host

1 reference

12 December 2020

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study

1 reference

12 December 2020

Prophylactic studies against herpes infections in severely immunocompromised patients with acyclovir

1 reference

12 December 2020

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

1 reference

12 December 2020

Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).

1 reference

12 December 2020

Psychiatric side-effects of acyclovir in patients with chronic renal failure

1 reference

12 December 2020

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

1 reference

12 December 2020

Topical acyclovir in the management of recurrent herpes labialis

1 reference

12 December 2020

The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.

1 reference

12 December 2020

A randomized double-blind placebo controlled trial of oral acyclovir in renal allograft recipients

1 reference

12 December 2020

Failure of acyclovir cream in treatment of recurrent herpes labialis

1 reference

12 December 2020

Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial

1 reference

12 December 2020

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center

1 reference

12 December 2020

Acyclovir-induced renal failure. Clinical course and histology

1 reference

12 December 2020

Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel

1 reference

12 December 2020

The acquisition of herpes simplex virus during pregnancy

1 reference

12 December 2020

Acyclovir Prevents Reactivation of Herpes Simplex Labialis in Skiers

1 reference

12 December 2020

Prevention of herpesvirus infections in renal allograft recipients by low-dose oral acyclovir

1 reference

12 December 2020

Psychiatric side-effects with acyclovir

1 reference

12 December 2020

1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention

1 reference

12 December 2020

Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes

1 reference

12 December 2020

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial

1 reference

12 December 2020

The management of herpes simplex virus infection in pregnancy

1 reference

12 December 2020

Herpes simplex virus infections during the decade since the licensure of acyclovir

1 reference

12 December 2020

Rapidly progressive acute renal failure due to acyclovir: case report and review of the literature

1 reference

12 December 2020

Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients

1 reference

12 December 2020

Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects

1 reference

12 December 2020

Mucocutaneous herpes simplex infections

1 reference

12 December 2020

Infections Caused by Herpes Simplex Virus in the Immunocompromised Host: Natural History And Topical Acyclovir Therapy

1 reference

12 December 2020

Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial

1 reference

12 December 2020

Herpes-simplex-virus infection after renal transplantation

1 reference

12 December 2020

A Trial of Topical Acyclovir in Genital Herpes Simplex Virus Infections

1 reference

12 December 2020

Recurrent genital herpes suppressed by oral acyclovir: a multicentre double blind trial

1 reference

12 December 2020

Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes

1 reference

12 December 2020

Topical acyclovir in the treatment of initial genital herpes

1 reference

12 December 2020

INTRAVENOUS ACYCLOVIR TREATMENT FOR PRIMARY GENITAL HERPES

1 reference

12 December 2020

Acute renal failure and coma secondary to acyclovir therapy

1 reference

12 December 2020

Prolonged oral acyclovir administration associated with neutropenia and thrombocytopenia

1 reference

12 December 2020

Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group

1 reference

12 December 2020

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

1 reference

12 December 2020

Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection

1 reference

12 December 2020

1 reference

12 December 2020

Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

1 reference

12 December 2020

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

1 reference

12 December 2020

Herpes simplex viruses

1 reference

12 December 2020

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

1 reference

12 December 2020

All Patients with Recurrent Genital Herpes Should be Offered Suppressive Therapy with Acyclovir

1 reference

12 December 2020

10.2165/00002018-200023020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1048124806

0 references

1 reference